Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Translational Biomarkers to Predict Clinical Response in Treatment-resistant Depression: Towards a Personalized, Plasticity-enhancing Accelerated Neuromodulation

NCT05798143 is registered in ClinicalTrials.gov with ITAB - Institute for Advanced Biomedical Technologies as lead sponsor.

NCT NCT05798143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05798143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Translational Biomarkers to Predict Clinical Response in Treatment-resistant Depression: Towards a Personalized, Plasticity-enhancing Accelerated Neuromodulation
Lead sponsor
ITAB - Institute for Advanced Biomedical Technologies
Phase
Not applicable
Overall status
Recruiting
Start date
February 28, 2023
Completion date
December 31, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression